ACUITYBIO
AcuityBio was founded by Mark Grinstaff, Ph.D., Alain Hanover, M.S., Jesse Wolinsky, Ph.D., and John 'Jay' Schwartz, Ph.D. in late 2009 to commercialize novel polymer drug delivery technologies to treat various types early stage, soft tissue cancers. AcuityBio's lead product candidate aimed at preventing the recurrence of non-small cell lung cancer is based on a synthetic polymer technology invented by co-founders Professor Mark Grinstaff, Ph.D. and Jesse Wolinsky, Ph.D. at Boston University (BU), Departments of Biomedical Engineering and Chemistry. AcuityBio is a privately-held company based in the Greater Boston area.
ACUITYBIO
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.acuitybio.com
Total Employee:
11+
Status:
Active
Total Funding:
2.45 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Microsoft Azure DNS GoDaddy DNS Wix GoDaddy Email Wix DNS
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
NextVivo
NextVivo is a biotech company developing an immune organoid technology platform.
Current Employees Featured
Official Site Inspections
http://www.acuitybio.com
- Host name: 104.21.12.126
- IP address: 104.21.12.126
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
